GlassScriptPhysician profile
Craig W Carmichael
NPI 1497761100
$2,766.74
in general payments reported to CMS, 2019-2025
18 companies · $178 in 2025
The $178 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.13 · 2020: $48.16 · 2021: $283 · 2022: $1,981 · 2023: $59.99 · 2024: $190 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $427.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,045.25 | 2022-2024 | Intellis Adaptivestim |
| Nevro Corp. | $282.91 | 2021 | |
| Si-Bone, INC. | $60.65 | 2020-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.21 | 2024-2025 | Hyqvia |
| Genzyme Corporation | $45.43 | 2025 | |
| Neurocrine Biosciences, INC. | $31.65 | 2024-2025 | Ingrezza |
| Orthofix Medical, INC. | $31.62 | 2024 | Spinal-Stim |
| Radius Health, INC. | $28.45 | 2020 | |
| Sk Life Science, INC. | $25.99 | 2024 | |
| Foundation Fusion Solutions, LLC | $25.76 | 2024 | |
| Acadia Pharmaceuticals INC | $23.46 | 2025 | Nuplazid |
| Abbvie INC. | $23.41 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $19.20 | 2025 | |
| Medline Industries LP | $17.77 | 2023 | |
| Csl Behring | $17.10 | 2024 | Hizentra |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $14.33 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.75 | 2024 | Austedo Xr |
| Pfizer INC. | $12.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Carmichael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.